Last price paid | 2.09 | |
Change | -2.34% [ -0.05 ] | |
Last traded volume | 150.00 Unit | |
Cumulative volume | 150.00 Unit | |
Date/time | 02.08.2024 12:56 |
Fixing | n.a. |
Settlement date | 23.10.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +68.75% |
Year to date (YTD) | +65.89% |
1 month | +48.61% |
3 months | +140.45% |
1 year | n.a. |
3 years | n.a. |
Issue price | 1.20 |
Underlying price on issue | 237.95 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281034657 |
Symbol | IROJ5Z |
Security | 128103465 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Funding level | 178.883200 |
Stop-loss level | 184.249700 |
Distance to stop-loss level | 34.27% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 19.10.2023 |
Premium | -0.06% |
Premium p.a. | n.a. |
Leverage | 2.77 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 101.416800 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Nestlé SA | 90.12 |
SWISSCOM N | 529.50 |
NOVARTIS N | 96.61 |
ROCHE GS | 279.40 |
Givaudan | 4'158.00 |
Name | Price |
---|---|
UBS | 24.26 |
ABB Ltd | 44.53 |
LOGITECH INT. | 73.26 |
Sika AG | 248.00 |
Partners Group Ho... | 1'101.50 |